CG Oncology (CGON) Receivables - Net (2023 - 2026)
CG Oncology (CGON) posted Receivables - Net of $1.3 million for Q1 2026, up 85.32% on a QoQ basis from $688000.0 in Q4 2025, and up 269.57% year-over-year from $345000.0 in Q1 2025.
CG Oncology (CGON) Receivables - Net (2023 - 2026) Analysis & Trends
CG Oncology's Receivables - Net history runs 4 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Receivables - Net rose 269.57% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 269.57% YoY) and the FY2025 annual result came in at $688000.0, changed N/A from the prior year.
- Receivables - Net was $1.3 million for Q1 2026 at CG Oncology, up from $688000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $1.3 million in Q1 2026 and bottomed at $92000.0 in Q4 2023.
- A 4-year average of $438777.8 and a median of $345000.0 in 2025 frame the typical range for Receivables - Net.
- Peak annual rise in Receivables - Net reached 275.91% in 2025, while the deepest fall reached 125.49% in 2025.
- CG Oncology's Receivables - Net stood at $92000.0 in 2023, then soared by 48.91% to $137000.0 in 2024, then jumped by 402.19% to $688000.0 in 2025, then soared by 85.32% to $1.3 million in 2026.
- Business Quant data shows CGON's Receivables - Net at $1.3 million in Q1 2026, $688000.0 in Q4 2025, and $515000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | CG Oncology | 5.86 Bn | 5.86 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 688,000.00 |
| Dec 31, 2025 | 688,000.00 |
| Sep 30, 2025 | 515,000.00 |
| Sep 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |